University of Sheffield tests available drugs for incurable breast cancer
The University of Sheffield in the UK has initiated a clinical trial to evaluate a combination of two existing drugs…
All articles by Divya Tirumalaraju
Divya Tirumalaraju
-
-
Elligo Health acquires clinical services firm ClinEdge for $135m
Elligo Health Research has acquired research practice management and clinical services firm ClinEdge in a $135m transaction. The deal was…
-
PathAI and Summit Clinical offer new solution for NASH trials
PathAI and Summit Clinical Research have partnered to offer an integrated clinical trial services solution for non-alcoholic steatohepatitis (NASH) drug…
-
Trialbee collaborates with Castor to boost access to trials
Trialbee has entered a strategic collaboration with Castor to boost access to clinical trials, fast-track participant enrolment and improve patient…
-
Gritstone starts Phase I dosing of second-gen mRNA Covid-19 vaccine
Clinical-stage biotech company Gritstone has dosed the first participants in a Phase I clinical trial of its second-generation, self-amplifying mRNA…
-
UK trial to assess mixed Covid-19 vaccine regimens in adolescents
A Phase II clinical trial, called Com-COV3, led by the University of Oxford has expanded to assess mixed Covid-19 vaccine…
-
Biogen reports positive Phase II data of non-opioid pain drug in SFN
Biogen has announced positive top-line data from the Phase II CONVEY clinical trial of its non-opioid oral pain drug candidate,…
-
Aerie’s dry eye therapeutic improves symptoms and signs in Phase IIb trial
Aerie Pharmaceuticals has announced positive top-line data from the Phase IIb COMET-1 clinical trial of the AR-15512 ophthalmic solution to…
-
City of Hope trials Covid-19 vaccine in immunocompromised patients
City of Hope, a biomedical research and cancer treatment centre, has started participant enrolment for Phase II clinical trial of…
-
AIVITA finds personalised Covid-19 vaccine generates immune response
AIVITA Biomedical has reported data from Phase II clinical trial of its anti-SARS-CoV-2 Vaccine Enabling Kit, which enables the creation…